Cue Biopharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $3,336 | $2,658 | $1,717 | $1,821 |
Gross Profit | 3,336 | -6,872 | 868 | 970 |
EBITDA | -7,593 | -9,090 | -11,257 | -12,076 |
EBIT | -8,472 | -9,956 | -12,106 | -12,927 |
Net Income | -8,660 | -10,171 | -12,347 | -13,434 |
Net Change In Cash | 3,336 | 2,658 | 1,717 | 1,821 |
Free Cash Flow | -7,526 | -10,000 | -9,839 | -10,958 |
Cash | 32,420 | 30,029 | 41,029 | 48,514 |
Basic Shares | 51,229 | 50,174 | 49,466 | 47,144 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $5,490 | $1,245 | $14,941 | $3,154 |
Gross Profit | -32,607 | -560 | 14,941 | -30,391 |
EBITDA | -46,052 | -50,490 | -45,490 | -43,985 |
EBIT | -49,488 | -52,296 | -43,712 | -45,042 |
Net Income | -50,733 | -52,795 | -44,161 | -44,784 |
Net Change In Cash | 5,490 | 1,245 | 14,941 | 3,154 |
Cost of Revenue | -12,756 | -10,495 | 30,576 | |
Free Cash Flow | -39,961 | -41,976 | -39,750 | -33,089 |
Cash | 48,514 | 51,614 | 64,370 | 74,866 |
Basic Shares | 45,754 | 35,649 | 31,285 | 28,688 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.17 |
2024-06-30 | -$0.20 |
2024-03-31 | -$0.25 |
2023-12-31 | -$0.29 |
